TRPV4对手的结构药理学
Junping Fan1, Chang Guo2, Daohong Liao3
1Beijing National Laboratory for Molecular Sciences, Key Laboratory of Bioorganic Chemistry and Molecular Engineering of Ministry of Education, College of Chemistry and Molecular Engineering, Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, 100871, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|April 25, 2024
概括
使用冷EM研究了两种强大的TRPV4抗剂,揭示了它们的结合部位和结合机制. 这项研究阐明了这些小分子如何抑制TRPV4通道,有助于未来的药物发现.
科学领域:
- 结构生物学 结构生物学
- 分子药理学分子药理学
背景情况:
- 暂时受体潜在阴离子通道子家族V成员4 (TRPV4) 对于生理功能至关重要.
- TRPV4功能障碍与各种疾病有关,包括,疼痛和神经退行.
- TRPV4对抗剂提供潜在的治疗益处,但它们的机制尚不清楚.
研究的目的:
- 阐明TRPV4对抗性的分子机制.
- 确定小分子抗剂对TRPV4抑制的结构基础.
主要方法:
- 低温电子显微镜 (cryo-EM) 用于确定人类TRPV4.4的高分辨率结构.
- 功能测试和分子动力学模拟来补充结构数据.
主要成果:
- 冷EM结构揭示了两个与TRPV4.4的电压感应类域 (VSLD) 结合的对抗剂.
- 反对者在封闭状态下稳定TRPV4通道,从而诱导对称过渡.
- 一个对手绑定到一个新的扩展口袋在VSLD.
结论:
- 这项研究为小分子抗剂对TRPV4调节提供了详细的机制性见解.
- 这些发现澄清了TRPV4抗剂的结合部位和抑制机制.
- 这些知识可以促进开发针对TRPV4治疗各种疾病的新疗法.
相关概念视频
Drug-Receptor Interaction: Antagonist
2.9K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
2.9K
Opioid Receptors: Overview
761
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
761
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.2K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.2K
Thermosensation
30.4K
Peripheral thermosensation is the perception of external temperature. A change in temperature (on the surface of the skin and other tissues) is detected by a family of temperature-sensitive ion channels called Transient Receptor Potential, or TRP, receptors. These receptors are located on free nerve endings. Those detecting cold temperatures are closer to the surface of the skin than the nerve endings detecting warmth. These thermoTRP channels, while temperature selective, have relatively...
30.4K
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
2.2K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.2K
Drug-Receptor Interaction: Agonist
2.5K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.5K


